Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.


BACKGROUND The incidence of metabolic syndrome-associated hepatocellular carcinoma (MS-HCC) is increasing. However, the results following liver resection in this context have not been described in detail. METHODS Data for all patients with metabolic syndrome as a unique risk factor for HCC who underwent liver resection between 2000 and 2011 were retrieved… (More)
DOI: 10.1002/bjs.8963


5 Figures and Tables

Slides referencing similar topics